Changes in the Characteristics and Long-term Mortality Rates of Intensive Care Unit Patients from 2003 to 2010: A Nationwide Population-Based Cohort Study Performed in the Republic of Korea

Jeongwon Heo; Yoonki Hong; Seon-Sook Han; Woo Jin Kim; Jae-Woo Kwon; Ki Won Moon; Jae Hoon Jeong; Young-Ju Kim; Seung-Hwan Lee; Seung-Joon Lee

doi:10.4266/acc.2018.00164

Articles

Page Path: HOME > Acute Crit Care > Volume 33(3); 2018 > Article

Original Article Changes in the Characteristics and Long-term Mortality Rates of Intensive Care Unit Patients from 2003 to 2010: A Nationwide Population-Based Cohort Study Performed in the Republic of Korea: Jeongwon Heo¹, Yoonki Hong², Seon-Sook Han², Woo Jin Kim², Jae-Woo Kwon^2,3, Ki Won Moon², Jae Hoon Jeong⁴, Young-Ju Kim⁴, Seung-Hwan Lee⁵, Seung-Joon Lee²; Acute and Critical Care 2018;33(3):135-145.
DOI: https://doi.org/10.4266/acc.2018.00164
Published online: August 31, 2018

¹Department of Internal Medicine, Kangwon National University Hospital, Chuncheon, Korea

²Department of Internal Medicine, Kangwon National University School of Medicine, Chuncheon, Korea

³Division of Allergy and Clinical Immunology, Kangwon National University School of Medicine, Chuncheon, Korea

⁴Department of Statistics, Kangwon National University, Chuncheon, Korea

⁵Department of Neurology, Kangwon National University School of Medicine, Chuncheon, Korea

Corresponding author Seung-Joon Lee Department of Internal Medicine, Kangwon National University School of Medicine, 1 Gangwondaehak-gil, Chuncheon 24341, Korea Tel: +82-33-258-9365 Fax: +82-33-255-6567 E-mail: medfman@gmail.com

• Received: May 3, 2018 • Revised: July 24, 2018 • Accepted: August 21, 2018

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

9,981 Views
167 Download
12 Web of Science
13 Crossref
12 Scopus

prev next

Full Article

Download PDF

Abstract
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
KEY MESSAGES
NOTES
Acknowledgments
SUPPLEMENTARY MATERIALS
REFERENCES

Abstract

Background
There are few studies on intensive care unit (ICU) patients in the Republic of Korea. We analyzed the characteristics and mortality changes of all ICU patients over the last 8 years.
Methods
This study used the cohort of the National Health Insurance Corporation, which provides medical care to all residents of the Republic of Korea. The cohort consists of patients aged 20 years or older between 2003 and 2010 with a history of ICU admission. We analyzed changes in sex, age, household income, number of hospital beds, emergency admissions, and reasons for admission using the Cochran–Armitage trend test. The adjusted hazard ratios (HRs) of mortality according to these variables and year of admission were calculated by Cox proportional hazards regression.
Results
The proportion of patients aged ≥70 years increased over that period, as did their average age (by 3.6 years). During the 8-year study period, the 3-year mortality rate was 32.91%–35.83%. The overall mortality was higher in males and older patients, in those with a lower household income and higher Charlson Comorbidity Index (CCI) score, those admitted to a hospital with a smaller number of beds, and those admitted via the emergency room. There was no significant change in crude mortality rate over the 8-year study period; however, the adjusted HR showed a decreasing trend.
Conclusions
Patients admitted to the ICU were older and had higher CCI score. Nevertheless, there was a temporal trend toward a decrease in the HR of long-term mortality.
Key Words: cohort studies; intensive care unit; mortality

INTRODUCTION

Over the past several decades, developments in medicine and increasing age of the population have led to many changes in the characteristics and mortality rates of patients admitted to the intensive care unit (ICU) [1]. The Korean population is aging rapidly, and the average life expectancy of Korean women born in 2030 is predicted to exceed 90 years [2]. These changes are likely to bring about further rapid aging and changes in the characteristics of patients admitted in ICUs in the Republic of Korea. In ICUs, treatment is highly intensive; consequently, the costs and mortality rates are also high [3,4]. The rates of ICU use are increasing; thus, the costs are also growing [5-7]. Therefore, there has been continuous interest in the consequences of changes in characteristics and mortality rates of ICU patients.

It is difficult to evaluate nationwide changes in ICU admissions due to variations in factors such as hospital volume and location and number of beds. A National Health Insurance Cohort sample has been established in the Republic of Korea comprising approximately 1 million people (2.2% of the total population), which can be considered representative of the general population [8]. Data from large cohorts on the characteristics and mortality rates of ICU admissions are available and is important for predicting changes in such characteristics [9,10].

This study used a nationwide cohort study, the National Health Insurance Service-National Sample Cohort (NHIS-NSC), to analyze the changes in characteristics of ICU patients and changes in mortality rate according to the factors of interest over the past 8 years. These data will be important to prepare for future trends in critical care needs in the ICU.

MATERIALS AND METHODS

Cohort and Patients

Korea has a single-payer national health system. The Korean National Health Insurance covers approximately 97% of the population in the Republic of Korea. We used the South Korean NHIS-NSC, which is a population-based cohort. A representative sample of about 1 million people, comprising 2.2% of the entire Korean population of 2002, was selected using systematic stratified random sampling, with proportional allocation to each stratum. All patients were followed up to 2013, unless they died or left the country. Loss of subjects due to death or emigration was compensated for by adding newborn data annually. Thus, the size of the cohort was maintained at 1 million up to 2013. The data include eligibility and demographic information, as well as medical treatments, prescriptions, and general health examination results [8].

Patients and Study Design

From the NHIS-NSC database containing data on 1,097,321 subscribers for the period of 2002–2010, the study population consisted of all patients >20 years old admitted to an ICU of a hospital with more than 300 beds and who were covered by the Korean National Health System between January 1, 2003 and December 31, 2010. In order to calculate 3-year mortality, subscribers of the NHIS-NSC between 2011 and 2013 were excluded. For calculation of the Charlson Comorbidity Index (CCI), patients admitted to the ICU in 2002 were excluded (n=1,888). The final number of ICU patients of interest during the study period was 25,400 (Figure 1). Factors of interest were sex, age, household income, CCI, hospital size, and reasons for admission, which have been studied in other ICU studies [11-14]. Household income in the NHIS-NCS was classified into deciles; in a further analysis, household income was divided into tertiles (low, deciles 0–4; middle, deciles 5–8; high, deciles 9–10). CCI was calculated according to main diagnosis and sub-diagnosis code during 1 year before the first day of ICU fee request according to the Korean Standard Classification of Diseases (KCD) codes of 17 diseases (Supplementary Table 1) [15]. Hospitals with ICUs were categorized into size tertiles (i.e., according to number of beds: 300–499, 500–803, >803). Reasons for admission were classified into eight categories according to KCD-6 (Supplementary Table 2), a modified version of the International Classification of Diseases, 10th revision. The study was reviewed by the Institutional Review Board of Kangwon National University Hospital (IRB No. KNUH-2018-01-001).

Statistical Analysis

The basic characteristics of the patients in this study were summarized as percentages and proportions, and the linear trends of the proportions of each category were tested by simple linear regressions. The crude mortality rate was calculated as the percentage of deaths of ICU patients admitted in each year for different follow-up periods since the first ICU admission, and the linear trends were examined using the Cochran-Armitage trend test. The chi-square test was performed for 90-day, 1-year, and 3-year mortality rates for each factor to compare differences in mortality according to factors. Cox proportional hazard regression was used to calculate adjusted hazard ratios (HRs) according to admission year to the ICU to determine whether the mortality of ICU patients showed an increasing or decreasing trend over years after adjusting for risk factors of interest. Patients who were alive or had dropped out by the end of the 3-year follow-up period were right-censored. Forest plots were constructed using adjusted HRs and their 95% confidence intervals in Cox models and stratified Cox models by admission reason. Statistical analyses were performed using SAS software version 9.4 (SAS Institute, Cary, NC, USA).

RESULTS

Temporal Trends in Patient Characteristics

During the 8-year period from 2003 to 2010, the number of applicable ICU admissions in Korea was 25,400. The proportion of males was higher than females in every year, by 9% to 20%. The proportion of patients aged ≥70 years increased over the study period, as did the average age (by 3.6 years). According to household income data, the proportion of patients from middle class households admitted to the ICU decreased over the study period. The proportion of patients with CCI ≥2 increased, as did the proportion of patients admitted to the ICU via the emergency room. The proportion of patients admitted with trauma and poisoning increased over the study period, while the proportions of those admitted with gastrointestinal and liver diseases and with endocrinological diseases including diabetes decreased. However, there were no changes in the proportions of ICU admissions due to infectious diseases, cardiovascular diseases, respiratory diseases, or cancer over the study period (Table 1, Supplementary Table 3).

Hazard Ratio of Mortality

During the 8-year study period, the 90-day mortality rate was 16.71%–18.93%, the 1-year mortality rate was 24.48%–26.54%, and the 3-year mortality rate was 32.91%–35.83% (Table 2). The 3-year mortality rate was higher in males, older subjects, those with a lower household income and higher CCI score, those admitted to a hospital with a smaller number of beds, and those admitted via the emergency room. Regarding the reasons for admission, mortality rate were higher in cases of infectious disease, cancer, and respiratory disease (Table 3). There was no significant difference among 90-day, 1-year mortality, and 3-year mortality. Significant risk factors for mortality within 3 years after ICU admission were male sex (adjusted HR, 1.24; 95% CI, 1.19 to 1.30), age ≥80 years (adjusted HR, 7.35; 95% CI, 5.84 to 9.25), lower household income (adjusted HR, 1.20; 95% CI, 1.14 to 1.27), CCI ≥3 (adjusted HR, 2.16; 95% CI, 1.98 to 2.36), admitted to a hospital with a small number of beds (adjusted HR, 1.25; 95% CI, 1.18 to 1.33), admission via the emergency room (adjusted HR, 1.56; 95% CI, 1.49 to 1.63), respiratory disease (adjusted HR, 2.56; 95% CI, 2.17 to 3.01), cancer (adjusted HR, 2.68; 95% CI, 2.29 to 3.13), and infectious disease (adjusted HR, 2.96; 95% CI, 2.49 to 3.52) (Table 4, Figure 2). These findings showed no difference in 90-day and 1-year mortality analyses except that adjusted HRs were higher for sex, age, and CCI as the duration after ICU admission increased.

Temporal Trend of Mortality

During the 8-year study period, the 3-year mortality rate was 32.91%–35.83%, and there was no significant temporal trend (Table 2); however, adjusted HRs showed a decrease. Compared with 2003, the HR has continued to decline significantly since 2007, achieving a value of 0.82 (95% CI, 0.76 to 0.90) in 2010 (Table 4). In an analysis stratified according to reason for ICU admission, only cardiovascular disease showed a decreasing trend from 2003 onward, with the lowest HR being 0.66 (95% CI, 0.57 to 0.77) in 2010. There was no decrease in HR for any other disease, including cancer and respiratory disease (Figure 3).

DISCUSSION

By reference to the data of a nationwide population-based cohort study, we examined changes in the characteristics and long-term survival rates of patients admitted to an ICU between 2003 and 2010. Patient age, CCI, rate of admission via the emergency room, and rate of admission to hospitals with a small number of beds all increased over the study period. There was a decreasing temporal trend in the HR of long-term mortality because of a reduction in mortality associated with cardiovascular disease.

An increase in average age of patients admitted to an ICU has been reported in several studies performed in developed countries [16]. In our study, the proportion of patients ≥70 years old increased over the study period, and the average age increased (by 3.6 years). In the future in the Republic of Korea, which is expected to have the most aged society in the world by 2030, patients admitted to the ICU are more likely to be of advanced age, and the proportion of patients ≥80 years old is likely to increase [2]. Therefore, it is necessary to prepare for the aging of patients admitted to the ICU. In particular, patients ≥80 years old showed a prominent increase in mortality rate in this study. This is an important result confirmed by the national cohort data. We should consider once more whether ICU admission is helpful for long-term survival in old age. Discussion about advance directives and patient’s decisions on life-sustaining treatment are increasingly necessary.

Differences in the proportions of ICU admissions by household income level were not marked. But, the adjusted risk of mortality was 1.2-fold higher in the lowest tertile versus the highest tertile. These findings agree with those of previous studies [13,17,18]. The adjusted HR of mortality at 90 days, 1-year, and 3-years was 1.2 (Table 4). It is important that both short-term and long-term care is affected by household income level with regard to mortality rate. This result implies that the physician needs to consider household income in treating critical illness and may consider a policy to reduce this difference.

The CCI has increased in patients admitted to the ICU. The HR of long-term mortality was also higher with a higher CCI. A number of physiological illness severity scoring systems have been developed in observational studies of ICU outcomes, such as the Simplified Acute Physiology Score (SAPS) [19], the Acute Physiology and Chronic Health Evaluation (APACHE) [20], and the Mortality Probability Model (MPM) [21]. However, the complexity and time constraints associated with these scoring systems limit their use in large population-based databases. Comorbidity has been shown to be an important determinant of ICU outcome [22,23]. Considering CCI in the patients admitted to an ICU will be helpful for predicting the long-term survival rate. In future study of ICU admission in association with mortality, it is better to accumulate evidence using CCI as well as a physiological illness severity scoring system.

We analyzed the data of hospitals with at least 300 beds; in these large hospitals, there was no significant change in the number of patients admitted to the ICU over the study period. The long-term mortality rate of ICU patients was significantly lower in larger versus smaller hospitals (31.15% vs. 39.88, respectively). Compared with large hospitals, the adjusted HR of long-term mortality in small hospitals was 1.25 (95% CI, 1.18 to 1.33). Additional analysis was performed on the characteristics of the patients according to number of hospital beds. For males, those with higher income and a CCI of 3 or greater tended to be admitted to large hospitals (Supplementary Table 4). It is important to understand the differences in the characteristics of large hospitals and small hospitals for preparation in future ICUs to prevent unbalanced inflow to large hospitals.

In our study, the mortality rate was highest for respiratory diseases and lowest for trauma and poisoning. There was no significant change in the crude HR of mortality over the study period; however, there was a significant difference in the adjusted HR. When analyzing admission reasons, there were no temporal trends toward a reduction in mortality, except for that due to cardiovascular disease. The HR of cardiovascular disease continued to decline from 2003. The reduction in mortality rate of the overall patient population was attributed to a decrease in mortality of patients hospitalized for cardiovascular disease. To our knowledge, there have been no previous reports on temporal trends in mortality by disease type among all patients admitted to ICUs in the Republic of Korea. There are many possible reasons for the reduction in mortality rate of cardiovascular disease, such as development of superior interventions, increased awareness of acute myocardial infarction among doctors and the general public, and improved care in coronary care units in recent decades [24]. We need to build a systematic database of diseases that have not shown improved survival rates over the past years, analyze the causes, and make improvements.

Our study had some limitations. First, we did not include widely used scoring systems. Second, the reason for ICU admission was based on the main diagnosis at admission, which may not always have corresponded to the actual reason for hospitalization. Despite these limitations, this study is important because it is first to analyze the characteristics and mortality rates of Korean ICU patients based on a nationally representative cohort.

From 2003 to 2010, the number of ICU admissions in the Republic of Korea increased, as did the age and disease severity of the patients. Meanwhile, the HR of long-term mortality gradually declined; in an analysis according to main diagnosis, this seemed to be due to the reduction in mortality rate of cardiovascular disease. Our research will be important in understanding the epidemiology of Korean ICU admission and preparing for change.

KEY MESSAGES

▪ From 2003 to 2010, patients admitted to the intensive care unit (ICU) in the Republic of Korea were older and had higher Charlson Comorbidity Index (CCI) scores.

▪ The ICU mortality was higher in males, elderly, those with a lower household income and higher CCI score.

▪ From 2003 to 2010, there was a temporal trend toward a decrease in the hazard ratio of long-term mortality in ICU admissions.

NOTES

No potential conflict of interest relevant to this article was reported.

Acknowledgments

This study was supported by 2015 Research Grant from Kangwon National University (No. 520150347). This study used National Health Insurance Service-National Sample Cohort data (NHIS-2018-2-112), made by National Health Insurance Service.

SUPPLEMENTARY MATERIALS

The online-only Supplement data are available with this article online: https://doi.org/10.4266/acc.2018.00164.

acc-2018-00164-suppl1.pdf

acc-2018-00164-suppl2.pdf

acc-2018-00164-suppl3.pdf

acc-2018-00164-suppl4.pdf

Figure 1.

Flow chart of the study selection process. NHIS-NSC: National Health Insurance Service-National Sample Cohort; ICU: intensive care unit.

Figure 2.

Forest plot of adjusted hazard ratio and 95% confidence interval in Cox models adjusted for sex, age, household income, Charlson Comorbidity Index, number of hospital beds, admission via the emergency room, and admission reason.

Figure 3.

The adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) of mortality and forest plots of HRs adjusted for sex, age, household income, Charlson comorbidity index, number of hospital beds, and admission via the emergency room in stratified Cox models by admission reason.

Table 1.

Basic characteristics of patients admitted to the ICU from 2003 to 2010

Variable	Total	2003	2004	2005	2006	2007	2008	2009	2010	β (P-value)^a
Total of ICU admission	25,400 (2.31)	2,938 (0.29)	3,091 (0.30)	2,947 (0.29)	3,089 (0.31)	3,296 (0.32)	3,315 (0.33)	3,412 (0.34)	3,312 (0.33)	0.007 (0.001)
Sex
Male	14,721 (57.96)	1,607 (54.7)	1,753 (56.71)	1,769 (60.03)	1,805 (58.43)	1,965 (59.62)	1,949 (58.79)	1,952 (57.21)	1,921 (58.00)	0.27 (0.337)
Female	10,679 (42.04)	1,331 (45.3)	1,338 (43.29)	1,178 (39.97)	1,284 (41.57)	1,331 (40.38)	1,366 (41.21)	1,460 (42.79)	1,391 (42.00)	-0.27 (0.337)
Age (yr)
20-29	787 (3.10)	121 (4.12)	125 (4.04)	87 (2.95)	90 (2.91)	94 (2.85)	112 (3.38)	91 (2.67)	67 (2.02)	-0.24 (0.008)
30-39	1,565 (6.16)	232 (7.90)	254 (8.22)	207 (7.02)	172 (5.57)	191 (5.79)	169 (5.10)	157 (4.60)	183 (5.53)	-0.47 (0.003)
40-49	3,286 (12.94)	421 (14.33)	470 (15.21)	416 (14.12)	383 (12.40)	417 (12.65)	398 (12.01)	408 (11.96)	373 (11.26)	-0.52 (0.001)
50-59	4,607 (18.14)	550 (18.72)	545 (17.63)	507 (17.20)	560 (18.13)	583 (17.69)	617 (18.61)	632 (18.52)	613 (18.51)	0.08 (0.390)
60-69	6,275 (24.70)	757 (25.77)	795 (25.72)	763 (25.89)	791 (25.61)	795 (24.12)	789 (23.80)	782 (22.92)	803 (24.25)	-0.38 (0.009)
70-79	5,952 (23.43)	605 (20.59)	616 (19.93)	645 (21.89)	728 (23.57)	810 (24.58)	824 (24.86)	902 (26.44)	822 (24.82)	0.85 (0.001)
≥80	2,928 (11.53)	252 (8.58)	286 (9.25)	322 (10.93)	365 (11.82)	406 (12.32)	406 (12.25)	440 (12.90)	451 (13.62)	0.69 (0.001)
Age (yr), mean±SD	62.15±15.37	60.02±15.58	59.95±15.76	61.54±15.42	62.59±15.13	62.74±15.32	62.79±15.34	63.53±15.03	63.63±14.92	0.56 (0.001)
Household income
High	7,740 (30.47)	904 (30.77)	948 (30.67)	852 (28.91)	942 (30.50)	977 (29.64)	999 (30.14)	1,075 (31.51)	1,043 (31.49)	0.14 (0.329)
Middle	9,674 (38.09)	1,113 (37.88)	1,243 (40.21)	1,139 (38.65)	1,208 (39.11)	1,272 (38.59)	1,256 (37.89)	1,237 (36.25)	1,206 (36.41)	-0.39 (0.043)
Low	7,986 (31.44)	921 (31.35)	900 (29.12)	956 (32.44)	939 (30.40)	1,047 (31.77)	1,060 (31.98)	1,100 (32.24)	1,063 (32.10)	0.24 (0.169)
CCI
0	3,961 (15.59)	550 (18.72)	593 (19.18)	462 (15.68)	454 (14.70)	474 (14.38)	480 (14.48)	483 (14.16)	465 (14.04)	-0.73 (0.005)
1	6,901 (27.17)	802 (27.30)	924 (29.89)	855 (29.01)	864 (27.97)	880 (26.70)	880 (26.55)	870 (25.50)	826 (24.94)	-0.56 (0.013)
2	4,934 (19.43)	545 (18.55)	535 (17.31)	563 (19.10)	603 (19.52)	691 (20.96)	634 (19.13)	676 (19.81)	687 (20.74)	0.34 (0.040)
≥3	9,604 (37.81)	1,041 (35.43)	1,039 (33.61)	1,067 (36.21)	1,168 (37.81)	1,251 (37.96)	1,321 (39.85)	1,383 (40.53)	1,334 (40.28)	0.95 (0.001)
Comorbidity
Myocardial infarction	1,825 (7.19)	212 (7.22)	220 (7.12)	218 (7.40)	267 (8.64)	241 (7.31)	247 (7.45)	221 (6.48)	199 (6.01)	-0.15 (0.226)
Congestive heart failure	860 (3.39)	128 (4.36)	94 (3.04)	102 (3.46)	121 (3.92)	114 (3.46)	98 (2.96)	106 (3.11)	97 (2.93)	-0.13 (0.072)
Peripheral vascular	449 (1.77)	53 (1.80)	58 (1.88)	58 (1.97)	46 (1.49)	67 (2.03)	53 (1.60)	67 (1.96)	47 (1.42)	0.03 (0.393)
Cerebrovascular	4,349 (17.12)	489 (16.64)	513 (16.6)	567 (19.24)	529 (17.13)	553 (16.78)	540 (16.29)	544 (15.94)	614 (18.54)	0.01 (0.961)
Dementia	90 (0.35)	4 (0.14)	0	5 (0.17)	18 (0.58)	13 (0.39)	8 (0.24)	23 (0.67)	19 (0.57)	0.07 (0.027)
Chronic pulmonary	919 (3.62)	109 (3.71)	123 (3.98)	103 (3.50)	117 (3.79)	140 (4.25)	111 (3.35)	111 (3.25)	105 (3.17)	-0.08 (0.135)
Rheumatology	45 (0.18)	5 (0.17)	12 (0.39)	3 (0.10)	5 (0.16)	3 (0.09)	7 (0.21)	5 (0.15)	5 (0.15)	-0.01 (0.416)
Peptic ulcer	835 (3.29)	112 (3.81)	103 (3.33)	104 (3.53)	106 (3.43)	94 (2.85)	124 (3.74)	103 (3.02)	89 (2.69)	-0.11 (0.072)
Mild liver	972 (3.83)	136 (4.63)	125 (4.04)	124 (4.21)	113 (3.66)	124 (3.76)	134 (4.04)	107 (3.14)	109 (3.29)	-0.17 (0.007)
Diabetes without chronic complications	909 (3.58)	78 (2.65)	75 (2.43)	78 (2.65)	79 (2.56)	155 (4.70)	143 (4.31)	145 (4.25)	156 (4.71)	0.36 (0.001)
Diabetes with chronic complications	352 (1.39)	42 (1.43)	36 (1.16)	37 (1.26)	47 (1.52)	60 (1.82)	53 (1.60)	45 (1.32)	32 (0.97)	-0.01 (0.776)
Hemiplegia or paraplegia	344 (1.35)	36 (1.23)	41 (1.33)	37 (1.26)	55 (1.78)	45 (1.37)	48 (1.45)	34 (1.00)	48 (1.45)	0.00 (0.987)
Renal	490 (1.93)	65 (2.21)	55 (1.78)	55 (1.87)	58 (1.88)	57 (1.73)	77 (2.32)	65 (1.91)	58 (1.75)	-0.01 (0.663)
Any malignancy, including leukemia and lymphoma	3,803 (14.97)	453 (15.42)	461 (14.91)	402 (13.64)	473 (15.31)	475 (14.41)	484 (14.60)	537 (15.74)	518 (15.64)	0.09 (0.450)
Moderate or severe liver	434 (1.71)	67 (2.28)	63 (2.04)	53 (1.80)	47 (1.52)	48 (1.46)	53 (1.60)	50 (1.47)	53 (1.60)	-0.09 (0.014)
Metastasis solid tumor	938 (3.69)	149 (5.07)	125 (4.04)	105 (3.56)	111 (3.59)	127 (3.85)	96 (2.90)	118 (3.46)	107 (3.23)	-0.20 (0.021)
AIDS/HIV	7 (0.03)	0	1 (0.03)	1 (0.03)	1 (0.03)	1 (0.03)	0	2 (0.06)	1 (0.03)	0.003 (0.313)
Hospital bed
>803	14,777 (58.18)	1,883 (64.09)	2,012 (65.09)	1,683 (57.11)	1,811 (58.63)	1,807 (54.82)	1,821 (54.93)	1,930 (56.57)	1,830 (55.25)	-1.36 (0.012)
500-803	7,223 (28.44)	752 (25.60)	761 (24.62)	835 (28.33)	867 (28.07)	1,013 (30.73)	1,003 (30.26)	986 (28.90)	1,006 (30.37)	0.75 (0.012)
300-499	3,400 (13.39)	303 (10.31)	318 (10.29)	429 (14.56)	411 (13.31)	476 (14.44)	491 (14.81)	496 (14.54)	476 (14.37)	0.61 (0.021)
Emergency admission
Emergency room	13,466 (53.02)	1,329 (45.23)	1,354 (43.80)	1,603 (54.39)	1,684 (54.52)	1,838 (55.76)	1,871 (56.44)	1,921 (56.30)	1,866 (56.34)	1.75 (0.011)
Others	11,934 (46.98)	1,609 (54.77)	1,737 (56.20)	1,344 (45.61)	1,405 (45.48)	1,458 (44.24)	1,444 (43.56)	1,491 (43.70)	1,446 (43.66)	-1.75 (0.011)
Admission reason
Cardiovascular	10,820 (42.60)	1,182 (40.23)	1,268 (41.02)	1,292 (43.84)	1,371 (44.38)	1,413 (42.87)	1,409 (42.50)	1,449 (42.47)	1,436 (43.36)	0.28 (0.211)
Cancer	4,608 (18.14)	548 (18.65)	540 (17.47)	482 (16.36)	568 (18.39)	581 (17.63)	594 (17.92)	656 (19.23)	639 (19.29)	0.20 (0.196)
Trauma/poisoning	2,736 (10.77)	289 (9.84)	277 (8.96)	324 (10.99)	317 (10.26)	394 (11.95)	384 (11.58)	372 (10.90)	379 (11.44)	0.29 (0.047)
Gastrointestinal/liver	2,656 (10.46)	351 (11.95)	376 (12.16)	317 (10.76)	332 (10.75)	323 (9.80)	345 (10.41)	320 (9.38)	292 (8.82)	-0.45 (0.001)
Respiratory	1,807 (7.11)	193 (6.57)	235 (7.60)	208 (7.06)	218 (7.06)	268 (8.13)	222 (6.70)	253 (7.42)	210 (6.34)	-0.03 (0.768)
Infectious	1,039 (4.09)	126 (4.29)	131 (4.24)	136 (4.61)	106 (3.43)	110 (3.34)	141 (4.25)	148 (4.34)	141 (4.26)	-0.01 (0.894)
Endocrinology	616 (2.43)	91 (3.10)	90 (2.91)	67 (2.27)	66 (2.14)	82 (2.49)	77 (2.32)	77 (2.26)	66 (1.99)	-0.12 (0.016)
Others	1,118 (4.40)	158 (5.38)	174 (5.63)	121 (4.11)	111 (3.59)	125 (3.79)	143 (4.31)	137 (4.02)	149 (4.50)	-0.15 (0.172)

Values are presented as the number of ICU patients (%) unless otherwise indicated.

ICU: intensive care unit; SD: standard deviation; CCI: Charlson Comorbidity Index; AIDS/HIV: acquired immune deficiency syndrome and human immunodeficiency virus infection.

^aβ: the slope parameter estimate of a simple linear regression of the proportion of each category on year; the P-value for the hypothesis β=0.

Table 2.

Annual mortality rate in the follow-up period at each admission year

Admission year	Mortality (%)
Admission year	90-Day	1-Year	3-Year
2003	491 (16.71)	726 (24.71)	971 (33.05)
2004	547 (17.70)	767 (24.81)	1,038 (33.58)
2005	558 (18.93)	782 (26.54)	1,056 (35.83)
2006	555 (17.97)	798 (25.83)	1,073 (34.74)
2007	555 (16.84)	807 (24.48)	1,090 (33.07)
2008	604 (18.22)	838 (25.28)	1,127 (34.00)
2009	613 (17.97)	837 (24.53)	1,123 (32.91)
2010	617 (18.63)	818 (24.70)	1,093 (33.00)
P-value^a	0.098	0.245	0.149

Values are presented as number (%).

^aCochran-Armitage trend tests.

Table 3.

The crude mortality rates in the follow-up period according to each variable

Variable	Mortality (%)
Variable	90-Day	P-value^a	1-Year	P-value^a	3-Year	P-value^a
Total	4,540 (17.87)		6,373 (25.09)		8,571 (33.74)
Sex		0.2226		0.0027		0.0001
Male	2,668 (18.12)		3,796 (25.79)		5,137 (34.90)
Female	1,872 (17.53)		2,577 (24.13)		3,434 (32.16)
Age (yr)		0.0001		0.0001		0.0001
20-29	52 (6.61)		62 (7.88)		78 (9.91)
30-39	150 (9.58)		187 (11.95)		238 (15.21)
40-49	379 (11.53)		485 (14.76)		637 (19.39)
50-59	589 (12.78)		790 (17.15)		1,075 (23.33)
60-69	926 (14.76)		1,381 (22.01)		1,923 (30.65)
70-79	1,385 (23.27)		1,983 (33.32)		2,690 (45.19)
≥80	1,059 (36.17)		1,485 (50.72)		1,930 (65.92)
Household income		0.0022		0.0001		0.0001
High	1,407 (18.18)		2,002 (25.87)		2,689 (34.74)
Middle	1,630 (16.85)		2,272 (23.49)		3,105 (32.10)
Low	1,503 (18.82)		2,099 (26.28)		2,777 (34.77)
CCI		0.0001		0.0001		0.0001
0	440 (11.11)		550 (13.89)		692 (17.47)
1	992 (14.37)		1,359 (19.69)		1,780 (25.79)
2	817 (16.56)		1,128 (22.86)		1,575 (31.92)
≥3	2,291 (23.85)		3,336 (34.74)		4,524 (47.11)
Hospital bed		0.0001		0.0001		0.0001
>803	2,385 (16.14)		3,371 (22.81)		4,603 (31.15)
500-803	1,410 (19.52)		1,950 (27.00)		2,612 (36.16)
300-499	745 (21.91)		1,052 (30.94)		1,356 (39.88)
Emergency admission		0.0001		0.0001		0.0001
Emergency room	2,893 (21.48)		3,959 (29.40)		5,110 (37.95)
Others	1,647 (13.80)		2,414 (20.23)		3,461 (29.00)
Admission reason		0.0001		0.0001		0.0001
Respiratory	616 (34.09)		812 (44.94)		1,007 (55.73)
Infectious	378 (36.38)		451 (43.41)		505 (48.60)
Cancer	1,084 (23.52)		1,631 (35.39)		2,261 (49.07)
Endocrinology	90 (14.61)		145 (23.54)		218 (35.39)
Gastrointestinal/liver	380 (14.31)		524 (19.73)		755 (28.43)
Cardiovascular	1,542 (14.25)		2,197 (20.30)		2,973 (27.48)
Trauma/poisoning	363 (13.27)		491 (17.95)		680 (24.85)
Others	87 (7.78)		122 (10.91)		172 (15.38)

Values are presented as number (%).

CCI: Charlson Comorbidity Index.

^aChi-square test.

Table 4.

The adjusted hazard ratios of mortality by Cox proportional hazards regression

Variable	Adjusted^a HR (95% CI)
Variable	90-Day mortality	1-Year mortality	3-Year mortality
Admission year
2003	1.00 (Reference)	1.00 (Reference)	1.00 (Reference)
2004	1.07 (0.95-1.21)	1.02 (0.92-1.13)	1.04 (0.95-1.14)
2005	1.04 (0.92-1.17)	0.99 (0.89-1.09)	1.01 (0.93-1.10)
2006	0.95 (0.84-1.07)	0.92 (0.83-1.01)	0.93 (0.85-1.01)
2007	0.85 (0.76-0.96)	0.83 (0.75-0.92)	0.83 (0.76-0.91)
2008	0.94 (0.83-1.05)	0.87 (0.79-0.96)	0.88 (0.80-0.95)
2009	0.88 (0.78-0.99)	0.80 (0.72-0.88)	0.79 (0.73-0.86)
2010	0.94 (0.83-1.06)	0.83 (0.75-0.92)	0.82 (0.76-0.90)
Sex
Female	1.00 (Reference)	1.00 (Reference)	1.00 (Reference)
Male	1.14 (1.07-1.21)	1.20 (1.14-1.26)	1.24 (1.19-1.30)
Age (yr)
20-29	1.00 (Reference)	1.00 (Reference)	1.00 (Reference)
30-39	1.40 (1.02-1.92)	1.45 (1.09-1.94)	1.47 (1.13-1.89)
40-49	1.59 (1.18-2.12)	1.66 (1.27-2.16)	1.71 (1.35-2.17)
50-59	1.65 (1.24-2.20)	1.80 (1.39-2.34)	1.93 (1.53-2.44)
60-69	1.84 (1.38-2.44)	2.24 (1.73-2.90)	2.51 (2.00-3.16)
70-79	2.92 (2.20-3.87)	3.58 (2.77-4.63)	4.11 (3.27-5.17)
≥80	4.73 (3.56-6.28)	6.13 (4.74-7.94)	7.35 (5.84-9.25)
Household income
High	1.00 (Reference)	1.00 (Reference)	1.00 (Reference)
Middle	1.08 (1.01-1.17)	1.07 (1.01-1.14)	1.10 (1.04-1.15)
Low	1.20 (1.11-1.29)	1.20 (1.13-1.28)	1.20 (1.14-1.27)
CCI
0	1.00 (Reference)	1.00 (Reference)	1.00 (Reference)
1	1.17 (1.04-1.31)	1.24 (1.12-1.37)	1.30 (1.18-1.42)
2	1.23 (1.09-1.40)	1.30 (1.17-1.44)	1.45 (1.32-1.59)
≥3	1.76 (1.58-1.97)	1.96 (1.78-2.16)	2.16 (1.98-2.36)
Hospital bed
>803	1.00 (Reference)	1.00 (Reference)	1.00 (Reference)
500-803	1.17 (1.09-1.25)	1.16 (1.09-1.22)	1.14 (1.09-1.20)
300-499	1.26 (1.16-1.37)	1.30 (1.21-1.39)	1.25 (1.18-1.33)
Emergency admissi	n
Others	1.00 (Reference)	1.00 (Reference)	1.00 (Reference)
Emergency room	1.71 (1.60-1.82)	1.67 (1.58-1.76)	1.56 (1.49-1.63)
Admission reason
Others	1.00 (Reference)	1.00 (Reference)	1.00 (Reference)
Cardiovascular	1.33 (1.07-1.65)	1.32 (1.10-1.58)	1.27 (1.09-1.48)
Respiratory	2.81 (2.24-3.53)	2.69 (2.22-3.26)	2.56 (2.17-3.01)
Cancer	2.43 (1.94-3.03)	2.62 (2.17-3.16)	2.68 (2.29-3.13)
Infectious	3.89 (3.07-4.91)	3.47 (2.84-4.25)	2.96 (2.49-3.52)
Endocrinology	1.33 (0.99-1.79)	1.50 (1.18-1.91)	1.66 (1.35-2.02)
Gastrointestinal/liver	1.38 (1.09-1.74)	1.34 (1.10-1.63)	1.39 (1.17-1.64)
Trauma/poisoning	1.33 (1.05-1.68)	1.28 (1.05-1.56)	1.30 (1.10-1.53)

HR: hazard ratio; CI: confidence interval; CCI: Charlson Comorbidity Index.

^aAdjusted for sex, age, house hold income, CCI, hospital beds, emergency admission, admission reason.

REFERENCES

1. Bagshaw SM, Webb SA, Delaney A, George C, Pilcher D, Hart GK, et al. Very old patients admitted to intensive care in Australia and New Zealand: a multi-centre cohort analysis. Crit Care 2009;13:R45. Article PubMed PMC
2. Kontis V, Bennett JE, Mathers CD, Li G, Foreman K, Ezzati M. Future life expectancy in 35 industrialised countries: projections with a Bayesian model ensemble. Lancet 2017;389:1323-35.Article PubMed PMC
3. Milbrandt EB, Kersten A, Rahim MT, Dremsizov TT, Clermont G, Cooper LM, et al. Growth of intensive care unit resource use and its estimated cost in Medicare. Crit Care Med 2008;36:2504-10.Article PubMed
4. Molina JA, Seow E, Heng BH, Chong WF, Ho B. Outcomes of direct and indirect medical intensive care unit admissions from the emergency department of an acute care hospital: a retrospective cohort study. BMJ Open 2014;4:e005553. Article PubMed PMC
5. Halpern NA, Pastores SM. Critical care medicine in the United States 2000-2005: an analysis of bed numbers, occupancy rates, payer mix, and costs. Crit Care Med 2010;38:65-71.Article PubMed
6. Halpern NA, Pastores SM, Greenstein RJ. Critical care medicine in the United States 1985-2000: an analysis of bed numbers, use, and costs. Crit Care Med 2004;32:1254-9.Article PubMed
7. Wallace DJ, Angus DC, Seymour CW, Barnato AE, Kahn JM. Critical care bed growth in the United States: a comparison of regional and national trends. Am J Respir Crit Care Med 2015;191:410-6.Article PubMed PMC
8. Lee J, Lee JS, Park SH, Shin SA, Kim K. Cohort profile: The National Health Insurance Service-National Sample Cohort (NHISNSC), South Korea. Int J Epidemiol 2017;46:e15. Article PubMed PDF
9. Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA 2014;311:1308-16.Article PubMed
10. Zimmerman JE, Kramer AA, Knaus WA. Changes in hospital mortality for United States intensive care unit admissions from 1988 to 2012. Crit Care 2013;17:R81. Article PubMed PMC
11. Mahmood K, Eldeirawi K, Wahidi MM. Association of gender with outcomes in critically ill patients. Crit Care 2012;16:R92. Article PubMed PMC
12. Fuchs L, Chronaki CE, Park S, Novack V, Baumfeld Y, Scott D, et al. ICU admission characteristics and mortality rates among elderly and very elderly patients. Intensive Care Med 2012;38:1654-61.Article PubMed PMC
13. Schnegelsberg A, Mackenhauer J, Nibro HL, Dreyer P, Koch K, Kirkegaard H. Impact of socioeconomic status on mortality and unplanned readmission in septic intensive care unit patients. Acta Anaesthesiol Scand 2016;60:465-75.Article PubMed
14. Christensen S, Johansen MB, Christiansen CF, Jensen R, Lemeshow S. Comparison of Charlson comorbidity index with SAPS and APACHE scores for prediction of mortality following intensive care. Clin Epidemiol 2011;3:203-11.Article PubMed PMC
15. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.Article PubMed
16. Sjoding MW, Prescott HC, Wunsch H, Iwashyna TJ, Cooke CR. Longitudinal changes in ICU admissions among elderly patients in the United States. Crit Care Med 2016;44:1353-60.Article PubMed PMC
17. Koch K, Nørgaard M, Schønheyder HC, Thomsen RW, Søgaard M; Danish Collaborative Bacteremia Network. Effect of socioeconomic status on mortality after bacteremia in workingage patients: a Danish population-based cohort study. PLoS One 2013;8:e70082.Article PubMed PMC
18. Hutchings A, Raine R, Brady A, Wildman M, Rowan K. Socioeconomic status and outcome from intensive care in England and Wales. Med Care 2004;42:943-51.Article PubMed
19. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993;270:2957-63.Article PubMed
20. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-29.Article PubMed
21. Lemeshow S, Teres D, Klar J, Avrunin JS, Gehlbach SH, Rapoport J. Mortality Probability Models (MPM II) based on an international cohort of intensive care unit patients. JAMA 1993;270:2478-86.Article PubMed
22. Ho KM, Knuiman M, Finn J, Webb SA. Estimating long-term survival of critically ill patients: the PREDICT model. PLoS One 2008;3:e3226.Article PubMed PMC
23. Johnston JA, Wagner DP, Timmons S, Welsh D, Tsevat J, Render ML. Impact of different measures of comorbid disease on predicted mortality of intensive care unit patients. Med Care 2002;40:929-40.Article PubMed
24. Jhun HJ, Kim H, Cho SI. Time trend and age-period-cohort effects on acute myocardial infarction mortality in Korean adults from 1988 to 2007. J Korean Med Sci 2011;26:637-41.Article PubMed PMC

Figure & Data

References

Citations

Citations to this article as recorded by

Three-year mortality, readmission, and medical expenses in critical care survivors: A population-based cohort study
Jiyeon Kang, Kwang Min Lee
Australian Critical Care.2024; 37(2): 251. CrossRef
Effects of Intensive Care Experience on Post-Intensive Care Syndrome among Critical Care Survivors : Partial Least Square-Structural Equation Modeling Approach
Young Shin Cho, Jiyeon Kang
Journal of Korean Critical Care Nursing.2024; 17(1): 30. CrossRef
The impact of age on mortality in the intensive care unit: a retrospective cohort study in Malaysia
Abdul Jabbar Ismail, W Mohd Nazaruddin W Hassan, Mohd Basri Mat Nor, Wan Fadzlina Wan Muhd Shukeri
Acute and Critical Care.2024; 39(3): 390. CrossRef
The Association Between Glycemic Variability and Mortality in Critically Ill Patients: A Multicenter Prospective Observational Study
Ömer Emgin, Mehmet Yavuz, Adem Şahin, Murat Güneş, Mustafa Eser, Tunzala Yavuz, Damla Kökalan, Bişar Ergün, Kazım Rollas, Mensure Yılmaz Çakırgöz
Journal of Clinical Medicine.2024; 13(22): 6939. CrossRef
Trends in Mortality after Intensive Care of Patients with Aneurysmal Subarachnoid Hemorrhage in Finland in 2003–2019: A Finnish Intensive Care Consortium study
Jyri J. Virta, Markus Skrifvars, Matti Reinikainen, Stepani Bendel, Ruut Laitio, Sanna Hoppu, Tero Ala-Kokko, Jari Siironen, Rahul Raj
Neurocritical Care.2022; 37(2): 447. CrossRef
Change in management and outcome of mechanical ventilation in Korea: a prospective observational study
Jae Kyeom Sim, Sang-Min Lee, Hyung Koo Kang, Kyung Chan Kim, Young Sam Kim, Yun Seong Kim, Won-Yeon Lee, Sunghoon Park, So Young Park, Ju-Hee Park, Yun Su Sim, Kwangha Lee, Yeon Joo Lee, Jin Hwa Lee, Heung Bum Lee, Chae-Man Lim, Won-Il Choi, Ji Young Hong
The Korean Journal of Internal Medicine.2022; 37(3): 618. CrossRef
Cardiac Dysfunction Is Not Associated with Increased Reintubation Rate in Patients Treated with Post-extubation High-Flow Nasal Cannula
Jae Kyeom Sim, Juwhan Choi, Jee Youn Oh, Kyung Hoon Min, Gyu Young Hur, Sung Yong Lee, Jae Jeong Shim, Young Seok Lee
Tuberculosis and Respiratory Diseases.2022; 85(4): 332. CrossRef
Characteristics and outcomes of patients admitted to adult intensive care units in Hong Kong: a population retrospective cohort study from 2008 to 2018
Lowell Ling, Chun Ming Ho, Pauline Yeung Ng, King Chung Kenny Chan, Hoi Ping Shum, Cheuk Yan Chan, Alwin Wai Tak Yeung, Wai Tat Wong, Shek Yin Au, Kit Hung Anne Leung, Jacky Ka Hing Chan, Chi Keung Ching, Oi Yan Tam, Hin Hung Tsang, Ting Liong, Kin Ip Law
Journal of Intensive Care.2021;[Epub] CrossRef
Neurointensive care results and risk factors for unfavorable outcome in aneurysmatic SAH: a comparison of two age groups
Vilja Välimäki, Teemu Luostarinen, Jarno Satopää, Rahul Raj, Jyri J. Virta
Acta Neurochirurgica.2021; 163(5): 1469. CrossRef
Long‐term trends in critical care admissions in Wales**
R. J. Pugh, R. Bailey, T. Szakmany, M. Al Sallakh, J. Hollinghurst, A. Akbari, R. Griffiths, C. Battle, C. Thorpe, C. P. Subbe, R. A. Lyons
Anaesthesia.2021; 76(10): 1316. CrossRef
Retrospective Analysis of Long-Term Survival in Very Elderly (age ≥80) Critically Ill Patients of a Medical Intensive Care Unit at a Tertiary Care Hospital in Korea
Seung Hun Lee, Ju-Young Kim, Tae Hoon Kim, Sun Mi Ju, Jung-Wan Yoo, Seung Jun Lee, Yu Ji Cho, Yi Yeong Jeong, Jong Deog Lee, Ho Cheol Kim
Tuberculosis and Respiratory Diseases.2020; 83(3): 242. CrossRef
Long-term mortality of patients discharged from the hospital after successful critical care in the ICU in Korea: a retrospective observational study in a single tertiary care teaching hospital
Se Hee Na, Cheung Soo Shin, Gwan Ho Kim, Jae Hoon Kim, Jong Seok Lee
Korean Journal of Anesthesiology.2020; 73(2): 129. CrossRef
Critical Care Research Using “Big Data”: A Reality in the Near Future
Kwangha Lee
Acute and Critical Care.2018; 33(4): 269. CrossRef

PubReader
ePub Link

Cite

CITE: export Copy Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

Changes in the Characteristics and Long-term Mortality Rates of Intensive Care Unit Patients from 2003 to 2010: A Nationwide Population-Based Cohort Study Performed in the Republic of Korea

Acute Crit Care. 2018;33(3):135-145. Published online August 31, 2018

DOI: https://doi.org/10.4266/acc.2018.00164

XML Download

Figure

Changes in the Characteristics and Long-term Mortality Rates of Intensive Care Unit Patients from 2003 to 2010: A Nationwide Population-Based Cohort Study Performed in the Republic of Korea

Figure 1. Flow chart of the study selection process. NHIS-NSC: National Health Insurance Service-National Sample Cohort; ICU: intensive care unit.

Figure 2. Forest plot of adjusted hazard ratio and 95% confidence interval in Cox models adjusted for sex, age, household income, Charlson Comorbidity Index, number of hospital beds, admission via the emergency room, and admission reason.

Figure 3. The adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) of mortality and forest plots of HRs adjusted for sex, age, household income, Charlson comorbidity index, number of hospital beds, and admission via the emergency room in stratified Cox models by admission reason.

Figure 1.

Figure 2.

Figure 3.

Changes in the Characteristics and Long-term Mortality Rates of Intensive Care Unit Patients from 2003 to 2010: A Nationwide Population-Based Cohort Study Performed in the Republic of Korea

Variable	Total	2003	2004	2005	2006	2007	2008	2009	2010	β (P-value)^a
Total of ICU admission	25,400 (2.31)	2,938 (0.29)	3,091 (0.30)	2,947 (0.29)	3,089 (0.31)	3,296 (0.32)	3,315 (0.33)	3,412 (0.34)	3,312 (0.33)	0.007 (0.001)
Sex
Male	14,721 (57.96)	1,607 (54.7)	1,753 (56.71)	1,769 (60.03)	1,805 (58.43)	1,965 (59.62)	1,949 (58.79)	1,952 (57.21)	1,921 (58.00)	0.27 (0.337)
Female	10,679 (42.04)	1,331 (45.3)	1,338 (43.29)	1,178 (39.97)	1,284 (41.57)	1,331 (40.38)	1,366 (41.21)	1,460 (42.79)	1,391 (42.00)	-0.27 (0.337)
Age (yr)
20-29	787 (3.10)	121 (4.12)	125 (4.04)	87 (2.95)	90 (2.91)	94 (2.85)	112 (3.38)	91 (2.67)	67 (2.02)	-0.24 (0.008)
30-39	1,565 (6.16)	232 (7.90)	254 (8.22)	207 (7.02)	172 (5.57)	191 (5.79)	169 (5.10)	157 (4.60)	183 (5.53)	-0.47 (0.003)
40-49	3,286 (12.94)	421 (14.33)	470 (15.21)	416 (14.12)	383 (12.40)	417 (12.65)	398 (12.01)	408 (11.96)	373 (11.26)	-0.52 (0.001)
50-59	4,607 (18.14)	550 (18.72)	545 (17.63)	507 (17.20)	560 (18.13)	583 (17.69)	617 (18.61)	632 (18.52)	613 (18.51)	0.08 (0.390)
60-69	6,275 (24.70)	757 (25.77)	795 (25.72)	763 (25.89)	791 (25.61)	795 (24.12)	789 (23.80)	782 (22.92)	803 (24.25)	-0.38 (0.009)
70-79	5,952 (23.43)	605 (20.59)	616 (19.93)	645 (21.89)	728 (23.57)	810 (24.58)	824 (24.86)	902 (26.44)	822 (24.82)	0.85 (0.001)
≥80	2,928 (11.53)	252 (8.58)	286 (9.25)	322 (10.93)	365 (11.82)	406 (12.32)	406 (12.25)	440 (12.90)	451 (13.62)	0.69 (0.001)
Age (yr), mean±SD	62.15±15.37	60.02±15.58	59.95±15.76	61.54±15.42	62.59±15.13	62.74±15.32	62.79±15.34	63.53±15.03	63.63±14.92	0.56 (0.001)
Household income
High	7,740 (30.47)	904 (30.77)	948 (30.67)	852 (28.91)	942 (30.50)	977 (29.64)	999 (30.14)	1,075 (31.51)	1,043 (31.49)	0.14 (0.329)
Middle	9,674 (38.09)	1,113 (37.88)	1,243 (40.21)	1,139 (38.65)	1,208 (39.11)	1,272 (38.59)	1,256 (37.89)	1,237 (36.25)	1,206 (36.41)	-0.39 (0.043)
Low	7,986 (31.44)	921 (31.35)	900 (29.12)	956 (32.44)	939 (30.40)	1,047 (31.77)	1,060 (31.98)	1,100 (32.24)	1,063 (32.10)	0.24 (0.169)
CCI
0	3,961 (15.59)	550 (18.72)	593 (19.18)	462 (15.68)	454 (14.70)	474 (14.38)	480 (14.48)	483 (14.16)	465 (14.04)	-0.73 (0.005)
1	6,901 (27.17)	802 (27.30)	924 (29.89)	855 (29.01)	864 (27.97)	880 (26.70)	880 (26.55)	870 (25.50)	826 (24.94)	-0.56 (0.013)
2	4,934 (19.43)	545 (18.55)	535 (17.31)	563 (19.10)	603 (19.52)	691 (20.96)	634 (19.13)	676 (19.81)	687 (20.74)	0.34 (0.040)
≥3	9,604 (37.81)	1,041 (35.43)	1,039 (33.61)	1,067 (36.21)	1,168 (37.81)	1,251 (37.96)	1,321 (39.85)	1,383 (40.53)	1,334 (40.28)	0.95 (0.001)
Comorbidity
Myocardial infarction	1,825 (7.19)	212 (7.22)	220 (7.12)	218 (7.40)	267 (8.64)	241 (7.31)	247 (7.45)	221 (6.48)	199 (6.01)	-0.15 (0.226)
Congestive heart failure	860 (3.39)	128 (4.36)	94 (3.04)	102 (3.46)	121 (3.92)	114 (3.46)	98 (2.96)	106 (3.11)	97 (2.93)	-0.13 (0.072)
Peripheral vascular	449 (1.77)	53 (1.80)	58 (1.88)	58 (1.97)	46 (1.49)	67 (2.03)	53 (1.60)	67 (1.96)	47 (1.42)	0.03 (0.393)
Cerebrovascular	4,349 (17.12)	489 (16.64)	513 (16.6)	567 (19.24)	529 (17.13)	553 (16.78)	540 (16.29)	544 (15.94)	614 (18.54)	0.01 (0.961)
Dementia	90 (0.35)	4 (0.14)	0	5 (0.17)	18 (0.58)	13 (0.39)	8 (0.24)	23 (0.67)	19 (0.57)	0.07 (0.027)
Chronic pulmonary	919 (3.62)	109 (3.71)	123 (3.98)	103 (3.50)	117 (3.79)	140 (4.25)	111 (3.35)	111 (3.25)	105 (3.17)	-0.08 (0.135)
Rheumatology	45 (0.18)	5 (0.17)	12 (0.39)	3 (0.10)	5 (0.16)	3 (0.09)	7 (0.21)	5 (0.15)	5 (0.15)	-0.01 (0.416)
Peptic ulcer	835 (3.29)	112 (3.81)	103 (3.33)	104 (3.53)	106 (3.43)	94 (2.85)	124 (3.74)	103 (3.02)	89 (2.69)	-0.11 (0.072)
Mild liver	972 (3.83)	136 (4.63)	125 (4.04)	124 (4.21)	113 (3.66)	124 (3.76)	134 (4.04)	107 (3.14)	109 (3.29)	-0.17 (0.007)
Diabetes without chronic complications	909 (3.58)	78 (2.65)	75 (2.43)	78 (2.65)	79 (2.56)	155 (4.70)	143 (4.31)	145 (4.25)	156 (4.71)	0.36 (0.001)
Diabetes with chronic complications	352 (1.39)	42 (1.43)	36 (1.16)	37 (1.26)	47 (1.52)	60 (1.82)	53 (1.60)	45 (1.32)	32 (0.97)	-0.01 (0.776)
Hemiplegia or paraplegia	344 (1.35)	36 (1.23)	41 (1.33)	37 (1.26)	55 (1.78)	45 (1.37)	48 (1.45)	34 (1.00)	48 (1.45)	0.00 (0.987)
Renal	490 (1.93)	65 (2.21)	55 (1.78)	55 (1.87)	58 (1.88)	57 (1.73)	77 (2.32)	65 (1.91)	58 (1.75)	-0.01 (0.663)
Any malignancy, including leukemia and lymphoma	3,803 (14.97)	453 (15.42)	461 (14.91)	402 (13.64)	473 (15.31)	475 (14.41)	484 (14.60)	537 (15.74)	518 (15.64)	0.09 (0.450)
Moderate or severe liver	434 (1.71)	67 (2.28)	63 (2.04)	53 (1.80)	47 (1.52)	48 (1.46)	53 (1.60)	50 (1.47)	53 (1.60)	-0.09 (0.014)
Metastasis solid tumor	938 (3.69)	149 (5.07)	125 (4.04)	105 (3.56)	111 (3.59)	127 (3.85)	96 (2.90)	118 (3.46)	107 (3.23)	-0.20 (0.021)
AIDS/HIV	7 (0.03)	0	1 (0.03)	1 (0.03)	1 (0.03)	1 (0.03)	0	2 (0.06)	1 (0.03)	0.003 (0.313)
Hospital bed
>803	14,777 (58.18)	1,883 (64.09)	2,012 (65.09)	1,683 (57.11)	1,811 (58.63)	1,807 (54.82)	1,821 (54.93)	1,930 (56.57)	1,830 (55.25)	-1.36 (0.012)
500-803	7,223 (28.44)	752 (25.60)	761 (24.62)	835 (28.33)	867 (28.07)	1,013 (30.73)	1,003 (30.26)	986 (28.90)	1,006 (30.37)	0.75 (0.012)
300-499	3,400 (13.39)	303 (10.31)	318 (10.29)	429 (14.56)	411 (13.31)	476 (14.44)	491 (14.81)	496 (14.54)	476 (14.37)	0.61 (0.021)
Emergency admission
Emergency room	13,466 (53.02)	1,329 (45.23)	1,354 (43.80)	1,603 (54.39)	1,684 (54.52)	1,838 (55.76)	1,871 (56.44)	1,921 (56.30)	1,866 (56.34)	1.75 (0.011)
Others	11,934 (46.98)	1,609 (54.77)	1,737 (56.20)	1,344 (45.61)	1,405 (45.48)	1,458 (44.24)	1,444 (43.56)	1,491 (43.70)	1,446 (43.66)	-1.75 (0.011)
Admission reason
Cardiovascular	10,820 (42.60)	1,182 (40.23)	1,268 (41.02)	1,292 (43.84)	1,371 (44.38)	1,413 (42.87)	1,409 (42.50)	1,449 (42.47)	1,436 (43.36)	0.28 (0.211)
Cancer	4,608 (18.14)	548 (18.65)	540 (17.47)	482 (16.36)	568 (18.39)	581 (17.63)	594 (17.92)	656 (19.23)	639 (19.29)	0.20 (0.196)
Trauma/poisoning	2,736 (10.77)	289 (9.84)	277 (8.96)	324 (10.99)	317 (10.26)	394 (11.95)	384 (11.58)	372 (10.90)	379 (11.44)	0.29 (0.047)
Gastrointestinal/liver	2,656 (10.46)	351 (11.95)	376 (12.16)	317 (10.76)	332 (10.75)	323 (9.80)	345 (10.41)	320 (9.38)	292 (8.82)	-0.45 (0.001)
Respiratory	1,807 (7.11)	193 (6.57)	235 (7.60)	208 (7.06)	218 (7.06)	268 (8.13)	222 (6.70)	253 (7.42)	210 (6.34)	-0.03 (0.768)
Infectious	1,039 (4.09)	126 (4.29)	131 (4.24)	136 (4.61)	106 (3.43)	110 (3.34)	141 (4.25)	148 (4.34)	141 (4.26)	-0.01 (0.894)
Endocrinology	616 (2.43)	91 (3.10)	90 (2.91)	67 (2.27)	66 (2.14)	82 (2.49)	77 (2.32)	77 (2.26)	66 (1.99)	-0.12 (0.016)
Others	1,118 (4.40)	158 (5.38)	174 (5.63)	121 (4.11)	111 (3.59)	125 (3.79)	143 (4.31)	137 (4.02)	149 (4.50)	-0.15 (0.172)

Admission year	Mortality (%)
Admission year	90-Day	1-Year	3-Year
2003	491 (16.71)	726 (24.71)	971 (33.05)
2004	547 (17.70)	767 (24.81)	1,038 (33.58)
2005	558 (18.93)	782 (26.54)	1,056 (35.83)
2006	555 (17.97)	798 (25.83)	1,073 (34.74)
2007	555 (16.84)	807 (24.48)	1,090 (33.07)
2008	604 (18.22)	838 (25.28)	1,127 (34.00)
2009	613 (17.97)	837 (24.53)	1,123 (32.91)
2010	617 (18.63)	818 (24.70)	1,093 (33.00)
P-value^a	0.098	0.245	0.149

Variable	Mortality (%)
Variable	90-Day	P-value^a	1-Year	P-value^a	3-Year	P-value^a
Total	4,540 (17.87)		6,373 (25.09)		8,571 (33.74)
Sex		0.2226		0.0027		0.0001
Male	2,668 (18.12)		3,796 (25.79)		5,137 (34.90)
Female	1,872 (17.53)		2,577 (24.13)		3,434 (32.16)
Age (yr)		0.0001		0.0001		0.0001
20-29	52 (6.61)		62 (7.88)		78 (9.91)
30-39	150 (9.58)		187 (11.95)		238 (15.21)
40-49	379 (11.53)		485 (14.76)		637 (19.39)
50-59	589 (12.78)		790 (17.15)		1,075 (23.33)
60-69	926 (14.76)		1,381 (22.01)		1,923 (30.65)
70-79	1,385 (23.27)		1,983 (33.32)		2,690 (45.19)
≥80	1,059 (36.17)		1,485 (50.72)		1,930 (65.92)
Household income		0.0022		0.0001		0.0001
High	1,407 (18.18)		2,002 (25.87)		2,689 (34.74)
Middle	1,630 (16.85)		2,272 (23.49)		3,105 (32.10)
Low	1,503 (18.82)		2,099 (26.28)		2,777 (34.77)
CCI		0.0001		0.0001		0.0001
0	440 (11.11)		550 (13.89)		692 (17.47)
1	992 (14.37)		1,359 (19.69)		1,780 (25.79)
2	817 (16.56)		1,128 (22.86)		1,575 (31.92)
≥3	2,291 (23.85)		3,336 (34.74)		4,524 (47.11)
Hospital bed		0.0001		0.0001		0.0001
>803	2,385 (16.14)		3,371 (22.81)		4,603 (31.15)
500-803	1,410 (19.52)		1,950 (27.00)		2,612 (36.16)
300-499	745 (21.91)		1,052 (30.94)		1,356 (39.88)
Emergency admission		0.0001		0.0001		0.0001
Emergency room	2,893 (21.48)		3,959 (29.40)		5,110 (37.95)
Others	1,647 (13.80)		2,414 (20.23)		3,461 (29.00)
Admission reason		0.0001		0.0001		0.0001
Respiratory	616 (34.09)		812 (44.94)		1,007 (55.73)
Infectious	378 (36.38)		451 (43.41)		505 (48.60)
Cancer	1,084 (23.52)		1,631 (35.39)		2,261 (49.07)
Endocrinology	90 (14.61)		145 (23.54)		218 (35.39)
Gastrointestinal/liver	380 (14.31)		524 (19.73)		755 (28.43)
Cardiovascular	1,542 (14.25)		2,197 (20.30)		2,973 (27.48)
Trauma/poisoning	363 (13.27)		491 (17.95)		680 (24.85)
Others	87 (7.78)		122 (10.91)		172 (15.38)

Variable	Adjusted^a HR (95% CI)
Variable	90-Day mortality	1-Year mortality	3-Year mortality
Admission year
2003	1.00 (Reference)	1.00 (Reference)	1.00 (Reference)
2004	1.07 (0.95-1.21)	1.02 (0.92-1.13)	1.04 (0.95-1.14)
2005	1.04 (0.92-1.17)	0.99 (0.89-1.09)	1.01 (0.93-1.10)
2006	0.95 (0.84-1.07)	0.92 (0.83-1.01)	0.93 (0.85-1.01)
2007	0.85 (0.76-0.96)	0.83 (0.75-0.92)	0.83 (0.76-0.91)
2008	0.94 (0.83-1.05)	0.87 (0.79-0.96)	0.88 (0.80-0.95)
2009	0.88 (0.78-0.99)	0.80 (0.72-0.88)	0.79 (0.73-0.86)
2010	0.94 (0.83-1.06)	0.83 (0.75-0.92)	0.82 (0.76-0.90)
Sex
Female	1.00 (Reference)	1.00 (Reference)	1.00 (Reference)
Male	1.14 (1.07-1.21)	1.20 (1.14-1.26)	1.24 (1.19-1.30)
Age (yr)
20-29	1.00 (Reference)	1.00 (Reference)	1.00 (Reference)
30-39	1.40 (1.02-1.92)	1.45 (1.09-1.94)	1.47 (1.13-1.89)
40-49	1.59 (1.18-2.12)	1.66 (1.27-2.16)	1.71 (1.35-2.17)
50-59	1.65 (1.24-2.20)	1.80 (1.39-2.34)	1.93 (1.53-2.44)
60-69	1.84 (1.38-2.44)	2.24 (1.73-2.90)	2.51 (2.00-3.16)
70-79	2.92 (2.20-3.87)	3.58 (2.77-4.63)	4.11 (3.27-5.17)
≥80	4.73 (3.56-6.28)	6.13 (4.74-7.94)	7.35 (5.84-9.25)
Household income
High	1.00 (Reference)	1.00 (Reference)	1.00 (Reference)
Middle	1.08 (1.01-1.17)	1.07 (1.01-1.14)	1.10 (1.04-1.15)
Low	1.20 (1.11-1.29)	1.20 (1.13-1.28)	1.20 (1.14-1.27)
CCI
0	1.00 (Reference)	1.00 (Reference)	1.00 (Reference)
1	1.17 (1.04-1.31)	1.24 (1.12-1.37)	1.30 (1.18-1.42)
2	1.23 (1.09-1.40)	1.30 (1.17-1.44)	1.45 (1.32-1.59)
≥3	1.76 (1.58-1.97)	1.96 (1.78-2.16)	2.16 (1.98-2.36)
Hospital bed
>803	1.00 (Reference)	1.00 (Reference)	1.00 (Reference)
500-803	1.17 (1.09-1.25)	1.16 (1.09-1.22)	1.14 (1.09-1.20)
300-499	1.26 (1.16-1.37)	1.30 (1.21-1.39)	1.25 (1.18-1.33)
Emergency admissi	n
Others	1.00 (Reference)	1.00 (Reference)	1.00 (Reference)
Emergency room	1.71 (1.60-1.82)	1.67 (1.58-1.76)	1.56 (1.49-1.63)
Admission reason
Others	1.00 (Reference)	1.00 (Reference)	1.00 (Reference)
Cardiovascular	1.33 (1.07-1.65)	1.32 (1.10-1.58)	1.27 (1.09-1.48)
Respiratory	2.81 (2.24-3.53)	2.69 (2.22-3.26)	2.56 (2.17-3.01)
Cancer	2.43 (1.94-3.03)	2.62 (2.17-3.16)	2.68 (2.29-3.13)
Infectious	3.89 (3.07-4.91)	3.47 (2.84-4.25)	2.96 (2.49-3.52)
Endocrinology	1.33 (0.99-1.79)	1.50 (1.18-1.91)	1.66 (1.35-2.02)
Gastrointestinal/liver	1.38 (1.09-1.74)	1.34 (1.10-1.63)	1.39 (1.17-1.64)
Trauma/poisoning	1.33 (1.05-1.68)	1.28 (1.05-1.56)	1.30 (1.10-1.53)

Table 1. Basic characteristics of patients admitted to the ICU from 2003 to 2010

Values are presented as the number of ICU patients (%) unless otherwise indicated.

ICU: intensive care unit; SD: standard deviation; CCI: Charlson Comorbidity Index; AIDS/HIV: acquired immune deficiency syndrome and human immunodeficiency virus infection.

β: the slope parameter estimate of a simple linear regression of the proportion of each category on year; the P-value for the hypothesis β=0.

Table 2. Annual mortality rate in the follow-up period at each admission year

Values are presented as number (%).

Cochran-Armitage trend tests.

Table 3. The crude mortality rates in the follow-up period according to each variable

Values are presented as number (%).

CCI: Charlson Comorbidity Index.

Chi-square test.

Table 4. The adjusted hazard ratios of mortality by Cox proportional hazards regression

HR: hazard ratio; CI: confidence interval; CCI: Charlson Comorbidity Index.

Adjusted for sex, age, house hold income, CCI, hospital beds, emergency admission, admission reason.